LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 22 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39 | -99.9% | 7 | -99.8% | 0.00% | – |
| Q2 2023 | $34,043 | +213.0% | 4,638 | +67.6% | 0.00% | – |
| Q1 2023 | $10,878 | -97.4% | 2,768 | -97.5% | 0.00% | – |
| Q3 2022 | $419,000 | -58.3% | 112,605 | -65.4% | 0.00% | -100.0% |
| Q2 2022 | $1,004,000 | +25.0% | 325,000 | +110.0% | 0.00% | – |
| Q1 2022 | $803,000 | -17.0% | 154,793 | -22.6% | 0.00% | -100.0% |
| Q4 2021 | $968,000 | -85.4% | 200,000 | -50.7% | 0.00% | -75.0% |
| Q1 2021 | $6,620,000 | – | 405,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |